In conclusion, as a pan-PI3K inhibitor, DHW-208 can inhibit the proliferation, migration, invasion and angiogenesis of HCC by inhibiting the activation of PI3K/AKT/mTOR signaling pathway, exhibiting robust anti-HCC activity both in vivo and in vitro. The gene discussed is MTOR; the disease is hepatocellular carcinoma.